KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Receivables (2016 - 2025)

Charles River Laboratories International has reported Receivables over the past 17 years, most recently at $719.3 million for Q4 2025.

  • Quarterly results put Receivables at $719.3 million for Q4 2025, changed 0.22% from a year ago — trailing twelve months through Dec 2025 was $719.3 million (changed 0.22% YoY), and the annual figure for FY2025 was $719.3 million, changed 0.22%.
  • Receivables for Q4 2025 was $719.3 million at Charles River Laboratories International, down from $748.3 million in the prior quarter.
  • Over the last five years, Receivables for CRL hit a ceiling of $818.7 million in Q3 2023 and a floor of $610.6 million in Q1 2021.
  • Median Receivables over the past 5 years was $755.4 million (2024), compared with a mean of $742.4 million.
  • Biggest five-year swings in Receivables: grew 22.35% in 2021 and later decreased 10.57% in 2024.
  • Charles River Laboratories International's Receivables stood at $657.6 million in 2021, then rose by 14.42% to $752.4 million in 2022, then increased by 7.14% to $806.1 million in 2023, then decreased by 10.57% to $720.9 million in 2024, then fell by 0.22% to $719.3 million in 2025.
  • The last three reported values for Receivables were $719.3 million (Q4 2025), $748.3 million (Q3 2025), and $780.4 million (Q2 2025) per Business Quant data.